Month: September 2024

Andrew MacGarvey & Conditor Capital launch Coronado Research to maximise the use of data and technology in drug development; Dr. Nicholas Edwards announced as Chair

LONDON, Sept. 5, 2024 /PRNewswire/ -- Coronado Research is a consultancy-led professional services organisation operating in the clinical development arena. The...

Tier-One Canadian Life and Health Insurance Carrier Selects Sapiens Insurance Platform to Foster Innovation, Drive Efficiency, and Improve Agent & Customer Experience

Sapiens Insurance Platform for Life & Annuities will provide one integrated solution to support all products and services throughout the...

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs

Company's Canalevia®-CA1 prescription drug is FDA conditionally approved for treatment of chemotherapy-induced diarrhea (CID) in dogs and is the first...

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1

Moderna's updated COVID-19 mRNA vaccine will be available for the 2024-2025 vaccination season, pending a European Commission authorization decision CAMBRIDGE,...

error: Content is protected !!